Stockreport

Halozyme Therapeutics (NASDAQ:HALO) Reports Bullish Q3 CY2025 [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF The company's full-year revenue guidance of $1.34 billion at the midpoint came in 1.5% above analysts' estimates. Its non-GAAP profit of $1.72 per share was 5.5% above a [Read more]